Expert Review| Volume 5, ISSUE 3, 100749, March 2023

Is conservative management of placenta accreta spectrum disorders practical in the United States?

Published:September 12, 2022DOI:
      This commentary discusses the issues related to conservative management (also called leaving the placenta in situ or intentional retention of the placenta) of placenta accreta spectrum disorders. Considerations related to placenta accreta spectrum disorder management in the United States are compared with France, where conservative management is a well-accepted management option. The history of placenta accreta spectrum disorder treatment is reviewed, finding that since 1937, the most common treatment in the United States been cesarean-hysterectomy without placental removal. Although definitive studies have yet to be conducted, a growing body of evidence suggests that conservative management is able to reduce maternal morbidity, compared with cesarean-hysterectomy. International and national guidelines from several countries are examined. Comparisons between the United States and France that are addressed in the commentary include population and geography, structure of the healthcare system, physician training and acceptability, and patient acceptability. Considering the differences between the countries, conservative management is feasible in the United States. Different options for placenta accreta spectrum disorder management should be rigorously researched in multicenter international collaborations. Conservative management should be considered as an option for women with placenta accreta spectrum disorders in the United States, especially for those desiring fertility preservation.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Irving F
        • Hertig A.
        A study of placenta accreta.
        Surg Gynecol Obstet. 1937; 64: 178-199
        • Palacios-Jaraquemada JM
        • Fiorillo A
        • Hamer J
        • Martínez M
        • Bruno C.
        Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique.
        J Matern Fetal Neonatal Med. 2022; 35: 275-282
        • Sentilhes L
        • Seco A
        • Azria E
        • et al.
        Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study.
        Am J Obstet Gynecol. 2022; 226 (.e1–24): 839
        • Schumann EA.
        Pathology of the third stage of labor with especial reference to the placental element.
        Med Rec Ann. 1940; 151: 381-384
        • DeLee JB
        • Greenhill JP.
        Pathology of the third stage.
        Principles and Practice of Obstetrics. 9th ed. WB Saunders Company, Philadelphia, PA1947: 708-709
        • Muir JC.
        Conservative treatment of placenta accreta with subsequent normal pregnancy.
        Am J Obstet Gynecol. 1948; 56: 807
        • Weekes LR
        • Greig LB.
        Placenta accreta. A twenty-year review.
        Am J Obstet Gynecol. 1972; 113: 76-82
        • McKeogh RP
        • D'Errico E
        Placenta accreta: clinical manifestations and conservative management.
        N Engl J Med. 1951; 245: 159-165
        • Shamshirsaz AA
        • Fox KA
        • Erfani H
        • et al.
        Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time.
        Am J Obstet Gynecol. 2017; 216 (.e1–5): 612
        • Sentilhes L
        • Kayem G
        • Mattuizzi A.
        Conservative approach: intentional retention of the placenta.
        Best Pract Res Clin Obstet Gynaecol. 2021; 72: 52-66
        • Eller AG
        • Porter TF
        • Soisson P
        • Silver RM.
        Optimal management strategies for placenta accreta.
        BJOG. 2009; 116: 648-654
        • Warshak CR
        • Ramos GA
        • Eskander R
        • et al.
        Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta.
        Obstet Gynecol. 2010; 115: 65-69
        • Angstmann T
        • Gard G
        • Harrington T
        • Ward E
        • Thomson A
        • Giles W.
        Surgical management of placenta accreta: a cohort series and suggested approach.
        Am J Obstet Gynecol. 2010; 202 (.e1–9): 38
        • Hoffman MS
        • Karlnoski RA
        • Mangar D
        • et al.
        Morbidity associated with nonemergent hysterectomy for placenta accreta.
        Am J Obstet Gynecol. 2010; 202 (.e1–5): 628
        • Shamshirsaz AA
        • Fox KA
        • Salmanian B
        • et al.
        Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach.
        Am J Obstet Gynecol. 2015; 212 (.e1–9): 218
        • Hobson SR
        • Kingdom JCP
        • Windrim RC
        • et al.
        Safer outcomes for placenta accreta spectrum disorders: a decade of quality improvement.
        Int J Gynaecol Obstet. 2022; 157: 130-139
        • Sentilhes L
        • Ambroselli C
        • Kayem G
        • et al.
        Maternal outcome after conservative treatment of placenta accreta.
        Obstet Gynecol. 2010; 115: 526-534
        • Sentilhes L
        • Kayem G
        • Ambroselli C
        • et al.
        Fertility and pregnancy outcomes following conservative treatment for placenta accreta.
        Hum Reprod. 2010; 25: 2803-2810
        • van Beekhuizen HJ
        • Stefanovic V
        • Schwickert A
        • et al.
        A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum.
        Acta Obstet Gynecol Scand. 2021; 100: 12-20
        • McCall SJ
        • Deneux-Tharaux C
        • Sentilhes L
        • et al.
        Placenta accreta spectrum - variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study.
        BJOG. 2022; 129: 1676-1685
        • Brown AD
        • Hart JM
        • Modest AM
        • et al.
        Geographic variation in management of patients with placenta accreta spectrum: an international survey of experts (GPASS).
        Int J Gynaecol Obstet. 2022; 158: 129-136
        • Baldwin HJ
        • Patterson JA
        • Nippita TA
        • et al.
        Maternal and neonatal outcomes following abnormally invasive placenta: a population-based record linkage study.
        Acta Obstet Gynecol Scand. 2017; 96: 1373-1381
        • Jauniaux E
        • Bhide A
        • Kennedy A
        • et al.
        FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening.
        Int J Gynaecol Obstet. 2018; 140: 274-280
        • Buca D
        • Liberati M
        • Calì G
        • et al.
        Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis.
        Ultrasound Obstet Gynecol. 2018; 52: 304-309
      1. The World Bank Group. World Bank Open Data. 2022. Available at: Accessed February 18, 2022.

      2. Statista, Inc. Degree of urbanization in the United States from 1970 to 2020. 2022. Available at: Accessed February 18, 2022.

      3. Statista, Inc. Total number of births in France from 2004 to 2020. 2022. Available at: Accessed March 9, 2022.

      4. March of Dimes. Maternity care deserts Across the U.S. 2020. Available at: Accessed January 9, 2022.

        • Sentilhes L
        • Deneux-Tharaux C
        • Kayem G.
        Conservative management or cesarean hysterectomy for placenta accreta spectrum? Local resources and organization of care matter.
        Am J Obstet Gynecol. 2022; 226: 872
        • Chevreul K
        • Durand-Zaleski I
        • Bahrami S
        • Hernández-Quevedo C
        • Mladovsky P.
        France: health system review. Geneva, Switzerland: World Health Organization. Regional Office for Europe.
        European Observatory on Health Systems and Policies. 2010;
      5. Tikkanen R, Osborn R, Mossialos E, Djordjevic A, Wharton GA. International health care system profiles. 2020. Available at: Accessed March 9, 2022.

        • Fraze T
        • Elixhauser A
        • Holmquist L
        • Johann J
        Public Hospitals in the United States.
        2008: Statistical Brief. vol.95. Agency for Healthcare Research and Quality (US), Rockville (MD)2006 (2008: Statistical Brief)
        • Health, United States
        With special feature on mortality.
        National Center for Health Statistics, Hyattsville, MD2018
        • Eslier M
        • Deneux-Tharaux C
        • Sauvegrain P
        • et al.
        Severe maternal morbidity among undocumented migrant women in the PreCARE prospective cohort study.
        BJOG. 2022; 129: 1762-1771
      6. Medicaid and CHIP Payment and Access Commission. Access in brief: pregnant women and Medicaid. 2018. Available at: Accessed April 6, 2022.

        • Johnston EM
        • McMorrow S
        • Alvarez Caraveo C
        • Dubay L
        Post-ACA, more than one-third of women with prenatal Medicaid remained uninsured before or after pregnancy.
        Health Aff (Millwood). 2021; 40: 571-578
      7. Kaiser Family Foundation. Medicaid postpartum coverage extension tracker. 2022. Available at: Accessed February 18, 2022.

        • Collins SL
        • Alemdar B
        • van Beekhuizen HJ
        • et al.
        Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta.
        Am J Obstet Gynecol. 2019; 220: 511-526
        • Jauniaux E
        • Alfirevic Z
        • Bhide AG
        • et al.
        Placenta praevia and placenta accreta: diagnosis and management: Green-top Guideline No. 27a.
        BJOG. 2019; 126: e1-48
        • Hobson SR
        • Kingdom JC
        • Murji A
        • et al.
        No. 383-screening, diagnosis, and management of placenta accreta spectrum disorders.
        J Obstet Gynaecol Can. 2019; 41: 1035-1049
        • American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine
        Obstetric Care Consensus No. 7: placenta accreta spectrum.
        Obstet Gynecol. 2018; 132: e259-e275
        • Sentilhes L
        • Vayssière C
        • Deneux-Tharaux C
        • et al.
        Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR).
        Eur J Obstet Gynecol Reprod Biol. 2016; 198: 12-21
      8. Sentilhes L, Vayssière C, Deneux-Tharaux C, et al Amended-November-2015_1.pdf?ext=.pdf. Placenta Accreta. Melbourne, Australia: The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.: Updated November 2015. Accessed April 5, 2022.

        • Fox KA
        • Shamshirsaz AA
        • Carusi D
        • et al.
        Conservative management of morbidly adherent placenta: expert review.
        Am J Obstet Gynecol. 2015; 213: 755-760
        • Sentilhes L
        • Deneux-Tharaux C
        • Kayem G.
        Assessing conservative management vs cesarean hysterectomy for placenta accreta spectrum: the importance of comparing data collected at the same study period.
        Am J Obstet Gynecol. 2022; 227: 365-366
        • Esakoff TF
        • Handler SJ
        • Granados JM
        • Caughey AB.
        PAMUS: placenta accreta management across the United States.
        J Matern Fetal Neonatal Med. 2012; 25: 761-765
        • Jolley JA
        • Nageotte MP
        • Wing DA
        • Shrivastava VK.
        Management of placenta accreta: a survey of Maternal-Fetal Medicine practitioners.
        J Matern Fetal Neonatal Med. 2012; 25: 756-760
        • O'Brien JM
        • Barton JR
        • Donaldson ES.
        The management of placenta percreta: conservative and operative strategies.
        Am J Obstet Gynecol. 1996; 175: 1632-1638
        • Saccone G
        • Migliorini S
        • Crocetto F
        • et al.
        Risk of unscheduled delivery in women with placenta accreta according to planned gestational age at delivery.
        J Matern Fetal Neonatal Med. 2021; ([Epub ahead of print])
        • Fishel Bartal M
        • Papanna R
        • Zacharias NM
        • et al.
        Planned versus unplanned delivery for placenta accreta Spectrum.
        Am J Perinatol. 2022; 39: 252-258
        • Einerson BD
        • Watt MH
        • Sartori B
        • Silver R
        • Rothwell E.
        Lived experiences of patients with placenta accreta spectrum in Utah: a qualitative study of semi-structured interviews.
        BMJ Open. 2021; 11e052766
        • Pineles BL
        • Coselli J
        • Ghorayeb T
        • et al.
        Leaving the placenta in situ in placenta accreta spectrum disorders: a single-center case series.
        Am J Perinatol. 2022; ([Epub ahead of print])